Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis-Reference-Cited by-同舟云学术

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Published:2016-04-27 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Duchnowska Renata, ,Pęksa Rafał,Radecka Barbara,Mandat Tomasz,Trojanowski Tomasz,Jarosz Bożena,Czartoryska-Arłukowicz Bogumiła,Olszewski Wojciech P.,Och Waldemar,Kalinka-Warzocha Ewa,Kozłowski Wojciech,Kowalczyk Anna,Loi Sherene,Biernat Wojciech,Jassem Jacek

Funder

Polish Society of Oncology.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0702-8.pdf

Reference53 articles.

1. Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, et al. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol. 2014;32:2959–66.

2. Dieci MV, Criscitiello C, Goubar A, Viale G, Conte P, Guarneri V, et al. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol. 2014;25:611–8.

3. Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann Oncol. 2014;25:1544–50.

4. Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02–98. J Clin Oncol. 2013;31:860–7.

5. Denkert C, von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, et al. Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. J Clin Oncol. 2015;33:983–91.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in breast cancer metastasis with special emphasis on metastasis to the brain;Pathology - Research and Practice;2024-08

2. Evolutionary Trend Analysis of Research on Immunotherapy for Brain Metastasis Based on Machine-Learning Scientometrics;Pharmaceuticals;2024-06-28

3. Programmed cell death-ligand 2: new insights in cancer;Frontiers in Immunology;2024-03-28

4. Effect of Topical Programmed Death-Ligand1 on Corneal Epithelium in Dry Eye Mouse;Biomolecules;2024-01-04

5. Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities;Journal of Hematology & Oncology;2023-12-16